Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
This study has been completed.
Study NCT00032734   Information provided by Sanofi-Aventis
First Received: March 29, 2002   Last Updated: June 16, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyponatremia
Additional conditions recognized in this trial
Inappropriate ADH Syndrome
Syndrome
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Disease
Endocrine System Diseases
Hypothalamic Diseases
Metabolic Diseases
Nervous System Diseases
Pathologic Processes
Pituitary Diseases
Water-Electrolyte Imbalance
Interventions listed in this trial
satavaptan (SR121463B)
Additional drug interventions recognized in this trial
Arginine Vasopressin
Vasopressins
More general drug interventions related to this trial
Antidiuretic Agents
Cardiovascular Agents
Coagulants
Hematologic Agents
Hemostatics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services